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Conclusion: All three generations of MLC are found to be 
highly stable with a significant improvement in stability for 
each generation. Thus, it is possible to make a highly 
accurate and precise calibration of the Elekta MLCs if an 
adequate calibration procedure is available.  
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Purpose or Objective: Hyperthermia is a powerful 
radiosensitizer for treatment of superficial tumors. The 
purpose of this study is the 3D-modeling and simulation of 
the simultaneous using of two antennas of our equipment. In 
particular, geometric and functional characterization of the 
antennas as a function of various tissues characteristics (skin, 
fat and muscle) were investigated. 
 
Material and Methods: The hyperthermia device is equipped 
with double arms, operating at a radiofrequency of 434 MHz, 
with a water automatic superficial cooling device. For 
temperature measures, it is equipped with an integrated 
Multichannel thermometer. The antennas are designed to 
cover areas from 7.2 × 19.7 cm2 up to 20.7 × 28.7 cm2. The 
applicators geometry have been reproduced in the CAD 
environment with a professional software based on the FDTD 
processing methods. In order to identify the distribution of 
specific absorption power rate in different types of tissues, 
several simulations have been performed, varying the 
relative thicknesses of a model consisting of skin, fat and 
muscle. Working incident power has been set equal to 100 
watt. Waterbolus temperature is assumed to be equal to 38 
°C  
 
Results: The numerical model of the applicator has been 
coupled to various models of tissue, the incident maximum 
power of 100W for 60 minutes, with a thickness of waterbolus 
equal to 10 mm. In particular, as the fat thickness is 
gradually increased, muscle layer temperatures decrease of 
about 0.04 °C per mm of fat layer. Setting the skin thickness, 
as the fat thickness increases, the maximum temperature and 
the penetration depth reached in the muscle decrease; 
increasing skin thickness, if the fat thickness increases, 
consequently the maximum temperatures reached in the 
muscle and the depth of penetration decrease. In particular, 
increasing the fat thickness, temperatures in the underlying 
muscles were gradually reduced (approximately 0.2 °C for 5 
mm fat raise). In the underlying muscle layer, maps were 
more homogeneous, with an approximately uniform power 
intensity decrease on the section plane. By varying 
waterbolus thickness, from 10 to 20 mm, the adaptation of 
the applicator coupled to tissue model undergoes small 
changes of the reflected power and, at the operating 
frequency, the model with thickness 17.5 mm showed to have 
the best reflection coefficient (-31.35 dB). The simultaneous 
use of the two antennas showed that only the 10% isoSAR are 
overlapping, and it demonstrates that it is possible to use 
both antennas in safety without possibility of hot spots in the 
tissue, varying also the thickness of the bolus. 
 
Conclusion: The numerical simulation allows to know in 
detail the temperature distribution to different levels of 
depth, in particular it demonstrate that it is possible the 
simultaneous using of two antennas to treat more lesion in 
the same hyperthermia treatment session without hot spot in 
the tissue.  
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Purpose or Objective: The purpose of this work was to test 
the dosimetric impact of using a novel liquid fiducial marker 
(BioXmark®) in a proton spot scanned system. 
 
Material and Methods: In order to test the clinical 
applicability of the new fiducial marker for proton therapy 
we measured the relative proton stopping power (RSP) of the 
liquid fiducial marker. Second, we measured the dose 
perturbation of a clinical pencil beam scanning proton beam 
of the liquid fiducial marker and three other commercially 
available solid markers for comparison by introducing them in 
a gelatin phantom. Dose perturbation was measured for 
several proton energies between 90 and 101 MeV at several 
distances after the markers in order to evaluate potential 
dose perturbation directly behind the markers, in the Bragg 
peak and after the Bragg Peak. Finally, we created proton 
therapy plans on five patients with locally advanced lung 
cancer and with the liquid fiducial marker implanted. Each 
treatment plans had 3-4 intensity modulated proton (IMPT) 
beams. We examined the markers impact on the dose 
distribution caused by the fiducial markers. This was done by 
first calculating the dose with no marker correction, secondly 
by matching the RSP of the fiducial marker with the 
experimental results, and subsequently with the RSP 
matching soft tissue and comparing changes in the dose 
distributions. 
 
Results: The RSP of the liquid fiducial marker was 
determined to be 1.164 and 1.174 experimentally and 
theoretically, respectively. The dose perturbation of the 
liquid fiducial marker showed no effect directly after the 
marker itself and only had an effect on the proton range 
(Figure 1). By introducing the fiducial markers, we estimated 
a median range deviation of 1.2 (range: 0.7-1.9 mm) of the 
proton beam as compared to soft tissue. On the clinical lung 
cancer IMPT plans with the correct RSP manually introduced, 
the spinal cord max dose, lung V20, PTV V95, CTV V95 and 
GTV V95 were all modified by less than 1% by introducing the 
markers. 
